Lipoprotein-Associated Phospholipase A 2 and C-Reactive Protein for Risk-Stratification of Patients With TIA | Zendy

Brett Cucchiara | Zendy; Steve R. Messé | Zendy; Lauren Sansing | Zendy; Larami Mackenzie | Zendy; Robert A. Taylor | Zendy; James Pacelli | Zendy; Qaisar A. Shah | Zendy; Scott E. Kasner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lipoprotein-Associated Phospholipase A ₂ and C-Reactive Protein for Risk-Stratification of Patients With TIA

Author(s) -

Brett Cucchiara,

Steve R. Messé,

Lauren Sansing,

Larami Mackenzie,

Robert A. Taylor,

James Pacelli,

Qaisar A. Shah,

Scott E. Kasner

Publication year - 2009

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.553545

Subject(s) - medicine , c reactive protein , gastroenterology , quartile , prospective cohort study , stroke (engine) , stenosis , population , clinical endpoint , confidence interval , inflammation , randomized controlled trial , mechanical engineering , environmental health , engineering

Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is a marker of unstable atherosclerotic plaque, and is predictive of both primary and secondary stroke in population-based studies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research